Schering Berlin Venture

Schering Berlin Venture was the corporate venture capital arm of the German pharmaceutical giant Schering AG. The firm specialized in early-to-mid-stage investments within the life sciences sector, particularly in biotechnology companies developing innovative therapeutics and platform technologies. Its investment strategy was closely aligned with Schering AG's strategic interests in areas such as oncology, women's health, and diagnostic imaging. Following the acquisition of Schering AG by Bayer in 2006, the venture arm's portfolio and operations were integrated into Bayer's corporate investment structure. During its active years, it was a prominent investor in the global biotech landscape, providing both capital and strategic partnerships to emerging startups.